OakChart

GeneDx Holdings Corp

WGSHealthcare·Diagnostics & Research·USA·Small·NASD·Nov 11 • 10:48 AM ET

59.00+4.17 (7.61%)
2026-11-11 16:48 CET
Market cap
1,635.17 USD m
Revenue, TTM
460.78 USD m
Net income, TTM
-111.05 USD m
Free cash flow, TTM
-101.22 USD m
EPS diluted, TTM
-3.78
P/E
-
Compare

Price

WGS against its 20, 50 and 200-day averages
2050200beat
40.0060.0080.00100.001.7M3.4MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26WGSclose 59.0020-day 64.9150-day 75.31200-day 70.3659.00

65.5% under the 52-week high of 170.87 on 2 Dec 2025. 52-week low 32.21 on 6 May 2026. Last 15 sessions, 35.2% high to low

Profile

WGS
52-week range, 19% of the way up
32.21170.87

GeneDx Holdings Corp. is a rare disease diagnosis company, with a mission to empower everyone to live their healthiest life through genomics. The firm combines clinical expertise, advanced technology, and the power of GeneDx Infinity. This foundation powers GeneDx's ExomeDx and GenomeDx tests, enabling clinicians to deliver precise, fast, and actionable diagnoses. The Infinity also fuels discovery for biopharma with AI-driven genomic intelligence. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

IndexRUT
Employees1300
IPONov 04, 2020
Beta2.02
ATR, 14d6.31
Rel volume1.04
Short float22.67%
Insider own3.10%
Inst own106.39%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.77B
Enterprise Value1.81B
Income-111.05M
Sales460.78M
Book/sh8.17
Cash/sh5.68
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees1300
IPONov 04, 2020

Ratios

P/E-
Forward P/E47.62
PEG4.00
P/S3.84
P/B7.22
P/C10.39
P/FCF-
EV/EBITDA-
EV/Sales3.94
Quick Ratio3.85
Current Ratio4.16
Debt/Eq0.88
LT Debt/Eq0.86
Option/ShortYes / Yes

Earnings

EPS (ttm)-3.78
EPS next Y1.24
EPS next Q0.37
EPS this Y-76.67%
EPS next Y279.25%
EPS next 5Y11.91%
EPS past 3/5Y76.08% 94.57%
Sales past 3/5Y22.13% 18.98%
EPS Y/Y TTM-5121.54%
Sales Y/Y TTM14.57%
EPS Q/Q-55.64%
Sales Q/Q5.45%
EarningsNov 09 AMC
EPS/Sales Surpr.284.09% 0.14%

Ownership

Insider Own3.10%
Insider Trans239.84%
Inst Own106.39%
Inst Trans-9.08%
ROA-21.77%
ROE-41.36%
ROIC-24.45%
Gross Margin65.01%
Oper. Margin-13.71%
Profit Margin-24.10%
SMA20-9.11%
SMA50-21.65%
SMA200-16.15%
Trades-

Technical

Shs Outstand29.95M
Shs Float28.90M
Short Float22.67%
Short Ratio8.40
Short Interest6.55M
52W High170.87 -65.47%
52W Low32.21 83.17%
Volatility9.97% 9.28%
ATR (14)6.31
RSI (14)42.07
Beta2.02
Rel Volume1.04
Avg Volume780.54K
Volume195,077

Performance

Perf Week-14.91%
Perf Month-9.17%
Perf Quarter-25.46%
Perf Half Y51.52%
Perf YTD-54.64%
Perf Year-57.83%
Perf 3Y4545.67%
Perf 5Y-77.40%
Perf 10Y-
Recom1.00
Target Price86.62
Prev Close54.83
Price59.00
Change %7.61%

Analyst ratings

latest 8 of 8
DateActionAnalystRating changeTargetImplied
Feb 09, 2026UpgradeWWells FargoEqual Weight → Overweight$155+162.7%
Oct 20, 2025InitiatedCCanaccord GenuityBuy$155+162.7%
Jul 09, 2025InitiatedPPiper SandlerOverweight$110+86.4%
May 15, 2025InitiatedGGuggenheimBuy$88+49.2%
May 09, 2025UpgradeJJefferiesHold → Buy$80+35.6%
Aug 28, 2024InitiatedWWells FargoEqual Weight$34-42.4%
Jul 10, 2024InitiatedCCraig HallumBuy$43-27.1%
Jun 03, 2024ResumedJJefferiesHold$21-64.4%

Peers

Mkt cap
TickerCompanyMkt cap
FLGTFulgent Genetics Inc745.00M
MYGNMyriad Genetics Inc559.71M
LHLabcorp Holdings Inc30.11B
TEMTempus AI Inc15.02B
NTRANatera Inc46.76B
BLLNBilliontoone Inc5.40B
DGXQuest Diagnostics Inc28.46B
PSNLPersonalis Inc1.73B
VCYTVeracyte Inc2.04B
ILMNIllumina Inc32.89B

Insider trading

latest 14 of 82
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Stueland KatherineCHIEF EXECUTIVE OFFICERSep 16 '26Option Exercise0.0018,7500125,977Sep 18 04:43 PM
Stueland KatherineCHIEF EXECUTIVE OFFICERSep 16 '26Sale97.6110,5011,025,013115,476Sep 18 04:43 PM
Feeley KevinCHIEF FINANCIAL OFFICERSep 16 '26Option Exercise0.007,197048,673Sep 18 04:39 PM
Feeley KevinCHIEF FINANCIAL OFFICERSep 16 '26Sale97.613,728363,89244,945Sep 18 04:39 PM
Fuchs ThomasDirectorSep 17 '26Option Exercise0.001,14601,146Sep 18 04:37 PM
Stueland KatherineCHIEF EXECUTIVE OFFICERSep 09 '26Option Exercise0.006,5470110,919Sep 11 04:13 PM
Stueland KatherineCHIEF EXECUTIVE OFFICERSep 09 '26Sale84.223,692310,932107,227Sep 11 04:13 PM
Feeley KevinCHIEF FINANCIAL OFFICERSep 09 '26Option Exercise0.002,462042,761Sep 11 04:10 PM
Feeley KevinCHIEF FINANCIAL OFFICERSep 09 '26Sale84.221,285108,22041,476Sep 11 04:10 PM
Feeley KevinCHIEF FINANCIAL OFFICERSep 01 '26Option Exercise0.00717040,671Sep 03 04:09 PM
Feeley KevinCHIEF FINANCIAL OFFICERSep 01 '26Sale83.8437231,18840,299Sep 03 04:09 PM
Kevin FeeleyOfficerSep 01 '26Proposed Sale84.755,410458,500Sep 01 06:06 PM
Katherine StuelandOfficerSep 09 '26Proposed Sale84.8214,2431,208,100Sep 01 06:05 PM
Ryan JasonDirectorJun 18 '26Option Exercise0.003,576015,480Jun 23 04:31 PM

Held by

AUM
TickerCompanyAUM
ARKEARK DIET Q3 Buffer ETFAUM: 1.45M
ARKKARK Innovation ETFAUM: 5.97B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
ARKGARK Genomic Revolution ETFAUM: 1.97B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
FESMFidelity Enhanced Small Cap Core ETFAUM: 6.82B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B

News

latest 14 of 206
  • 4 Post-Earnings Losers Drawing Unusual Options Volume (Schaeffer's Research) -16.57%
  • GeneDx Research Demonstrates Medical Actionability of Exome and Genome Sequencing Results in Large Real-World Study of More Than 300,000 Patients (Business Wire)
  • GeneDx Crushes EPS Consensus On Margin Gains, But Lower Volume Guidance Exposes A Business Trading Growth For Profitability (Earnings Whispers) +5.37%
  • GeneDx shares tumble on lowered growth targets (Investing.com)
  • GeneDx Reports Third Quarter 2026 Financial Results (Business Wire)
  • Loading…
  • GeneDx and Mirum Pharmaceuticals Launch Sponsored Testing Programs to Help Patients Find Answers Through Comprehensive Genetic Testing (Business Wire) -7.18%
  • GeneDx Must Show Carelon Coverage Gains Are Reaching Its Collection Rates (Earnings Whispers) -7.20% +7.10%
  • Did GeneDx Holdings Corp. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire)
  • GeneDx to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026 (Business Wire) -16.37% +9.10%
  • GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis (Business Wire)
  • GeneDx Advances Clinical Adoption of Genomic Medicine with 27 Abstracts at ASHG 2026 (Business Wire)
  • GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026 (Business Wire)
  • GeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric Care (Business Wire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-090.2800.073-0.410123.1122.937
2026Q22026-08-030.010-0.188-0.597114.44111.018
2026Q12026-05-04-0.280-0.015-2.158102.25112.468
2025Q42026-02-230.1400.102-0.608121120.328
2025Q32025-10-280.4900.423-0.265116.74104.627
2025Q22025-07-290.5000.1160.363102.6985.456
2025Q12025-04-300.2750.059-0.23287.1279.465
2024Q42025-02-180.7710.1630.19495.6482.244
2024Q32024-10-290.040-0.215-0.30776.6064.984
2024Q22024-07-30-0.107-0.300-1.09670.5159.313
2024Q12024-04-29-0.330-0.667-0.77762.4249.453
2023Q42024-02-20-0.491-0.653-0.99258.1054.243
2023Q32023-10-30-0.821-1.310-1.64053.3052.423
2023Q22023-08-08-1.648-1.313-1.83848.7147.593
2023Q12023-05-09-2.438-1.574-3.04043.1440.144
2022Q42023-03-14-29.700-6.084-26.22661.3570.964

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2021FY-74.910-34.540-74.927212.2203.77
2022FY-53.790-29.041-53.627234.69244.28
2023FY-5.194-5.353-7.230194.4192.76
2024FY0.254-0.266-1.944305.45290.22
2025FY1.4001.358-0.730427.54426.85
2026FY-0.327--477.28
2027FY-1.239--576.61
2028FY-1.962--722.75
2029FY-3.307--824.3
2030FY-4.885--984.55

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-10806137.42135143.6
2026Q4S2026-11-09800142.64139.2144.2
2026Q4S2026-10-24800142.64139.2144.2
2026Q4S2026-10-21810142.64139.2144.2
2026Q4S2026-10-18820142.64139.2144.2
2026Q4S2026-10-16870142.64139.2144.2
2026Q4S2026-09-28870142.64139.2144.2
2026Q4S2026-08-10970142.26139.2144.2
2026Q4S2026-08-07960141.76137.9144.2
2026Q4S2026-08-04950141.36135.6144.2
2026Q4S2026-07-26900139.04135.6142.25
2026Q4S2026-07-21901139.04135.6142.25
2026Q4S2026-07-20901139.04135.6142.25
2026Q4S2026-07-19902139.04135.6142.25

Estimate history

EPS, annual-1552176.964-74.927-53.627-7.23-1.944-0.734-3.7762
Period202020212022202320242025TTM
EPS, quarterly-0.3070.194-0.2320.363-0.265-0.608-2.158-0.597-0.413
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual179.322212.195234.694202.566305.45427.539460.78
Period202020212022202320242025TTM
Sales, quarterly76.87495.6487.115102.692116.743120.989102.254114.44123.101
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual07.35311.77325.97928.01729.24529.954
Period202020212022202320242025MRQ
Shares, quarterly27.43428.01728.5328.70828.8929.24529.66629.80329.954
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Total Revenue460.78427.54305.45202.57234.69212.19179.32
Cost of Goods Sold Incl. D&A161.21149.22128.96141.94289.43236.51177.97
Gross Profit299.57278.32176.4960.62-54.73-24.321.35
Selling, General and Administrative Excl. Other362.76290.12194.54217.06363.53416.34243.34
Research and Development78.9570.8444.8051.5671.2499.3471.66
Other Operating Expense0.000.003.417.220.000.000.00
Operating Income-63.19-11.80-21.46-163.66-418.26-440.65-241.99
Interest Expense4.202.543.03-3.212.832.47
Unusual Expense40.212.4815.1215.76179.16-192.910.00
Net Income Before Taxes-111.21-21.14-52.63-176.69-598.03-245.39-241.34
Income Taxes-0.16-0.12-0.34-0.93-49.050.000.00
Consolidated Net Income-111.05-21.02-52.29-175.77-548.98-245.39-241.34
Net Income From Continuing Operations-111.05-21.02-52.29-175.77-548.98-245.39-241.34
Net Income-111.05-21.02-52.29-175.77-548.98-245.39-241.34
EPS (Recurring)-2.77-0.67-1.55-6.78-41.38-116.16-1,552,176.96
EPS (Basic, Before Extraordinaries)-3.78-0.73-1.94-7.23-53.63-74.93-1,552,176.96
EPS (Diluted)-3.78-0.73-1.94-7.23-53.63-74.93-1,552,176.96
EBITDA-35.8913.420.49-127.83-355.23-417.29-227.86
Non-Operating Income (Expense)-3.61-4.32-13.012.732.605.193.13
Other After Tax Adjustments0.000.000.000.000.000.000.00
Stock Option Compensation Expense24.0725.417.22-0.2633.16219.42120.23
Price To Sales Ratio4.698.716.770.330.382.270.00
Gross Margin65.0165.1057.7829.93-23.32-11.460.75
Operating Margin-13.71-2.76-7.03-80.79-178.22-207.66-134.95
Net Margin-24.10-4.92-17.12-86.77-233.91-115.64-134.58
Shares Outstanding29.9529.2528.0225.9811.777.350.00
Market Capitalization1,635.171,635.172,111.4571.18100.621,082.21611.00

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue123.10114.44102.25120.99116.74102.6987.1195.64
Cost of Goods Sold Incl. D&A38.6141.1439.3942.0737.3236.5933.2434.06
Gross Profit84.4973.3062.8678.9279.4366.1053.8761.58
Selling, General and Administrative Excl. Other94.0587.4688.6192.6482.5557.0757.8751.69
Research and Development16.9918.3519.5824.0319.5914.8712.2111.28
Other Operating Expense0.000.000.000.000.000.000.000.79
Operating Income-9.56-14.16-25.75-13.72-3.129.03-3.999.10
Interest Expense1.781.190.720.520.560.820.640.70
Unusual Expense0.873.0835.750.523.53-2.111.662.27
Net Income Before Taxes-12.30-18.26-62.42-18.23-7.3910.56-6.085.41
Income Taxes0.03-0.520.90-0.560.25-0.250.45-0.02
Consolidated Net Income-12.33-17.74-63.32-17.67-7.6310.81-6.535.44
Net Income From Continuing Operations-12.33-17.74-63.32-17.67-7.6310.81-6.535.44
Net Income-12.33-17.74-63.32-17.67-7.6310.81-6.535.44
EPS (Recurring)-0.39-0.52-1.31-0.60-0.180.31-0.190.25
EPS (Basic, Before Extraordinaries)-0.41-0.60-2.16-0.61-0.270.38-0.230.19
EPS (Diluted)-0.41-0.60-2.16-0.61-0.270.36-0.230.19
EBITDA-2.67-7.45-18.94-6.843.3515.221.6914.66
Non-Operating Income (Expense)-0.090.16-0.21-3.48-0.170.240.21-0.71
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense6.525.017.115.448.366.173.152.25
Price To Earnings Ratio---2,156.885,761.50---
Price To Sales Ratio4.694.494.268.847.717.587.557.05
Gross Margin68.6364.0561.4865.2368.0464.3761.8464.38
Operating Margin-7.77-12.37-25.18-11.34-2.688.80-4.589.51
Net Margin-10.01-15.50-61.92-14.60-6.5410.53-7.495.69
Shares Outstanding29.9529.8029.6729.2528.8928.7128.5328.02
Market Capitalization1,635.172,038.081,880.923,759.333,094.962,633.902,485.872,111.45

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY
Cash & Short Term Investments171.28141.19130.15137.40400.57108.13
Short Term Receivables74.3737.6332.8243.3426.5632.33
Inventories13.9510.658.7813.6633.4624.96
Other Current Assets8.698.5010.6018.2122.968.68
Total Current Assets268.29197.97182.34212.62483.54174.11
Net Property, Plant & Equipment69.1158.5159.3884.2862.7263.11
Total Investments and Advances0.990.990.990.900.000.00
Long-Term Note Receivable----0.9010.83
Intangible Assets182.00158.60172.62186.65-0.00
Deferred Tax Assets46.4845.3254.9254.32--
Other Assets3.323.323.436.496.933.60
Total Assets570.19464.70473.67545.26554.09251.64
Short Term Debt Incl. Current Port. of LT Debt8.954.554.1410.873.423.51
Accounts Payable2.467.9510.2446.0244.6926.74
Other Current Liabilities97.5042.3244.4487.4153.1743.20
Total Current Liabilities108.9154.8258.82144.30101.2873.44
Long Term Debt104.22112.83115.6366.2629.4339.75
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities47.2446.2956.4856.98--
Other Liabilities1.645.5214.7324.0235.28134.06
Total Liabilities262.01219.46245.66291.56165.99247.25
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.00334.44
Common Equity308.18245.25228.02253.71388.10-330.05
Total Shareholders Equity308.18245.25228.02253.71388.104.39
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity308.18245.25228.02253.71388.104.39
Total Liabilities & Stockholders Equity570.19464.70473.67545.26554.09251.64
Book Value Per Share10.548.758.7821.5552.78-87,836,153.23
Tangible Book Value Per Share4.313.092.135.7052.78-87,836,153.23
Full-Time Employees1,3001,0001,0001,1001,2003
Price to Book Ratio6.7110.310.280.182.791.43
Return on Assets-4.06-11.14-34.50-99.87-49.17-
Return on Equity-7.60-22.10-72.97-171.07-60.10-
Return on Invested Capital-5.10-14.60-51.15-171.57-58.77-546.80
Quick Ratio2.343.422.951.384.442.03
Current Ratio2.463.613.101.474.772.37

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Net Income-111.05-21.02-52.29-175.77-548.98-245.39-241.34
Depreciation27.3025.2221.9533.7361.5323.3614.13
Other Funds (Non Cash)68.8144.6726.930.13134.4122.98120.23
Funds from Operations-14.9948.88-3.75-141.91-353.04-199.05-106.97
Extraordinary Item0.000.000.000.000.000.000.00
Changes in Working Capital-60.09-15.60-24.75-38.2433.888.0813.85
Cash from Operating Activities-75.0833.28-28.50-180.15-319.15-190.97-93.13
Capital Expenditures-26.14-19.02-5.49-5.71-14.32-20.79-31.97
Net Assets From Acquisitions0.34-32.860.00-12.14-127.000.000.00
Sale of Fixed Assets and Businesses0.000.000.004.030.000.000.00
Purchase or Sale of Investments-15.58-9.64-24.64-29.910.000.000.00
Purchase of Investments-60.00-55.68-66.30-47.670.000.000.00
Sale Or Maturity of Investments44.4246.0341.6617.770.000.000.00
Other Uses0.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.00
Cash from Investing Activities-41.38-61.52-30.13-43.73-141.33-20.79-31.97
Cash Dividends Paid0.000.000.000.000.000.000.00
Change in Capital Stock31.2051.6947.39143.29200.61793.96117.32
Repurchase of Common Pref Stock0.000.000.000.000.000.000.00
Sale of Common Pref Stock31.2051.6947.39143.29200.61793.96117.32
Proceedsfrom Stock Options27.9346.7046.50143.00197.66792.68117.32
Issuance or Reduction of Debt, Net85.42-3.66-3.2342.95-3.29-13.4711.73
Change in Long Term Debt85.42-3.66-3.2342.95-3.29-13.4711.73
Issuance of Long Term Debt146.030.000.0048.550.000.0015.93
Reduction of Long Term Debt-60.60-3.66-3.23-5.60-3.29-13.47-4.20
Net Financing Active Other Cash Flow0.000.000.000.000.00-286.220.00
Other Financing Activities Uses0.000.000.000.000.00-286.220.00
Cash from Financing Activities116.6348.0244.16186.24197.31494.27129.06
Net Change in Cash0.1719.79-14.47-37.63-263.17282.513.95
Free Cash Flow-101.2214.26-33.99-185.40-326.31-200.37-117.22
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.00
Price to Free Cash Flow-261.19-----
Deferred Taxes & Investment Tax Credit-0.00-0.340.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments170.12132.55170.69171.28155.08134.56
Short Term Receivables92.1383.6176.9374.3760.9448.03
Inventories21.7017.8212.2413.9510.5711.93
Other Current Assets12.9412.3810.778.6911.0010.32
Total Current Assets296.89246.36270.63268.29237.58204.84
Net Property, Plant & Equipment85.9487.8584.7869.1166.6265.10
Total Investments and Advances0.990.990.990.990.990.99
Intangible Assets139.37142.99146.61182.00185.38189.62
Deferred Tax Assets---46.48--
Other Assets3.293.293.293.323.323.32
Total Assets526.48481.49506.30570.19493.90463.86
Short Term Debt Incl. Current Port. of LT Debt5.825.715.138.955.664.31
Accounts Payable3.325.1511.172.462.633.52
Other Current Liabilities62.2663.7771.3497.5079.3363.58
Total Current Liabilities71.4074.6387.64108.9187.6271.41
Long Term Debt209.56161.69163.06104.22108.73111.30
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities0.760.871.4047.241.030.75
Other Liabilities0.070.070.071.644.263.27
Total Liabilities281.80237.26252.18262.01201.64186.73
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity244.69244.22254.12308.18292.26277.13
Total Shareholders Equity244.69244.22254.12308.18292.26277.13
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity244.69244.22254.12308.18292.26277.13
Total Liabilities & Stockholders Equity526.48481.49506.30570.19493.90463.86
Book Value Per Share8.178.198.5710.5410.129.65
Tangible Book Value Per Share3.523.403.624.313.703.05
Full-Time Employees---1,300--
Price to Book Ratio6.718.016.0912.8611.1610.23
Return on Assets-21.77-22.50-16.33-4.060.460.33
Return on Equity-41.36-40.80-30.42-7.600.840.60
Return on Invested Capital-2.71-4.37-15.18-4.28-1.902.78
Quick Ratio3.853.062.952.342.592.70
Current Ratio4.163.303.092.462.712.87

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-12.33-17.74-63.32-17.67-7.6310.81
Depreciation6.896.716.816.886.476.19
Other Funds (Non Cash)9.365.2046.367.8819.5510.00
Funds from Operations3.95-6.34-9.25-3.3518.6426.76
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-14.55-22.64-23.160.26-2.87-16.34
Cash from Operating Activities-10.60-28.98-32.41-3.0915.7710.42
Capital Expenditures-5.22-10.11-6.45-4.35-6.17-2.37
Net Assets From Acquisitions0.000.000.000.340.00-33.20
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-2.194.48-10.80-7.061.49-0.79
Purchase of Investments-11.79-8.89-20.18-19.14-5.76-13.56
Sale Or Maturity of Investments9.6013.379.3812.087.2512.78
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-7.42-5.63-17.25-11.07-4.69-36.35
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock5.00-95.2097.5323.8811.981.20
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock5.00-95.2097.5323.8811.981.20
Proceedsfrom Stock Options5.00-95.2097.0021.1411.80-0.13
Issuance or Reduction of Debt, Net48.8496.21-58.94-0.68-1.22-0.85
Change in Long Term Debt48.8496.21-58.94-0.68-1.22-0.85
Issuance of Long Term Debt49.3396.700.000.000.000.00
Reduction of Long Term Debt-0.49-0.49-58.94-0.68-1.22-0.85
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities53.841.0038.5923.1910.770.35
Net Change in Cash35.82-33.61-11.079.0321.85-25.58
Free Cash Flow-15.82-39.09-38.86-7.449.608.05
Price to Free Cash Flow---264.88200.613,309.14

Revenue breakdown

Diagnostic Test, Institutional Customers2024: 65.12M 2025: 70.07M
Diagnostic Test, Self Pay2024: 2.34M 2025: 1.36M
Diagnostic Test, Third Party Insurance2024: 234.70M 2025: 345.24M
Product and Service, Other2024: 3.29M 2025: 10.87M
United States2024: 305.45M 2025: 427.54M
GeneDx2024: 302.29M 2025: 423.09M
Other Operating2024: 3.16M 2025: 4.45M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3022.67%6.6M28.9M766.50K
2026-10-1520.83%6.0M28.9M724.58K
2026-09-3019.47%5.6M28.9M724.60K
2026-09-1521.38%5.9M27.5M729.60K
2026-08-3121.80%6.0M27.5M854.77K
2026-08-1422.84%6.3M27.5M1.00M
2026-07-3121.24%5.8M27.5M1.34M
2026-07-1521.27%5.8M27.4M1.32M
2026-06-3021.69%5.9M27.4M1.31M
2026-06-1521.92%6.0M27.4M1.26M
2026-05-2917.56%4.6M26.0M1.20M
2026-05-1518.93%4.9M26.1M1.11M
2026-04-3016.24%4.2M26.0M731.29K
2026-04-1515.44%4.0M25.7M761.49K
2026-03-3115.35%3.9M25.7M773.78K
2026-03-1315.04%3.9M25.7M701.74K
2026-02-2713.62%3.5M25.7M621.54K
2026-02-1314.80%3.8M25.7M585.49K
2026-01-3014.27%3.6M25.4M539.48K
2026-01-1514.28%3.6M25.4M536.38K

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call30.0027.0030.100.005.6280.000.000.992-0.0950.001
call32.5024.5027.3023.403.8605.000.000.991-0.0940.001
call35.0021.8025.200.004.7630.000.000.990-0.0930.001
call37.5019.5022.700.004.2450.000.000.989-0.0920.001
call40.0017.0019.9014.803.0501.000.000.988-0.0900.001
call42.0015.0017.8012.902.3704.000.000.986-0.0880.002
call42.5014.5017.3012.402.3003.000.000.986-0.0880.002
call43.0013.9017.000.002.8220.000.000.986-0.0870.002
call44.0013.0016.100.002.8530.000.000.985-0.0870.002
call45.0012.0015.100.002.6850.000.000.984-0.0860.002
call46.0011.0014.000.002.3410.000.000.962-0.1910.004
call47.0010.0013.007.412.1858.000.000.943-0.2720.005
call48.009.0012.206.572.3358.000.000.939-0.2660.005
call49.008.0011.006.701.8791.000.000.934-0.2600.006
call50.007.1010.004.701.72858.000.000.929-0.2540.006
call51.006.108.900.001.4160.000.000.923-0.2460.006
call52.005.108.000.001.4290.000.000.916-0.2380.007
call53.004.106.902.941.1383.000.000.897-0.2600.008
call54.003.906.004.821.12911.004.000.866-0.3010.010
call55.003.304.904.390.85947.004.000.831-0.3330.011
call56.002.504.103.301.00420.004.000.775-0.3990.013
call57.001.703.601.601.1115.002.000.705-0.4790.015
call58.001.102.751.800.9952525.000.641-0.5070.017
call59.000.501.759.400.79225.000.000.567-0.6040.018
call60.000.401.201.300.7716.0031.000.496-0.5080.018
call61.000.001.050.220.9181550.000.445-0.6290.018
call62.000.001.207.301.1182.000.000.393-0.6360.017
call63.000.000.700.250.93148.000.000.307-0.4920.016
call64.000.050.850.161.08060.000.000.255-0.4560.014
call65.000.150.600.301.28195.001,0480.190-0.3850.012
call66.000.000.550.151.35412050.000.176-0.3820.012
call67.000.000.700.061.56136.000.000.159-0.4080.011
call68.000.000.950.051.75027.001.000.156-0.4510.011
call69.000.000.556.461.81580.000.000.151-0.4610.010
call70.000.000.750.101.8883381.000.137-0.4480.010
call71.000.000.350.051.7666146.000.099-0.3340.008
call72.000.000.750.251.8165.000.000.097-0.3390.008
call73.000.000.756.101.99844.000.000.090-0.3500.007
call74.000.000.255.801.9351800.000.070-0.2780.006
call75.000.000.250.102.10620.000.000.076-0.3240.006
call76.000.000.300.052.19311.000.000.074-0.3290.006
call77.000.000.304.802.2781.000.000.071-0.3340.006
call78.000.000.300.052.1951102000.062-0.2930.006
call79.000.000.304.972.4429.000.000.067-0.3430.006
call80.000.000.300.052.3543710.000.059-0.3010.005
call81.000.000.300.052.5995.000.000.064-0.3510.006
call82.000.000.552.532.50529.000.000.056-0.3080.005
call83.000.001.801.102.75139.000.000.061-0.3580.005
call84.000.002.153.692.6523.000.000.053-0.3140.005
call85.000.000.500.052.74371.000.000.052-0.3180.005
call86.000.002.151.972.8133.000.000.051-0.3210.005
call87.000.002.151.052.86149.000.000.050-0.3230.005
call88.000.002.153.302.9491.000.000.049-0.3260.005
call89.000.002.150.003.0150.000.000.048-0.3290.004
call90.000.000.950.053.10133.000.000.047-0.3320.004
call91.000.001.601.952.8041.000.000.023-0.1640.002
call92.000.002.000.053.2292020.000.046-0.3370.004
call93.000.002.150.063.2501780.000.045-0.3380.004
call94.000.001.100.032.97210.000.000.022-0.1650.002
call95.000.002.101.043.37227.000.000.044-0.3430.004
call1000.002.100.033.85072.000.000.047-0.4060.004
call1050.000.600.603.96246.000.000.039-0.3610.004
call1100.002.150.034.1851200.000.037-0.3700.004
put30.000.002.000.154.0272140.00-0.008-0.0920.001
put32.500.000.150.203.53316.000.00-0.009-0.0900.001
put35.000.000.750.903.16512.000.00-0.010-0.0890.001
put37.500.000.750.602.7063.000.00-0.011-0.0860.001
put40.000.000.300.052.3531040.00-0.013-0.0840.001
put42.000.000.100.132.2054.000.00-0.014-0.0840.002
put42.500.000.100.182.54810.000.00-0.041-0.2350.004
put43.000.000.101.512.0754.000.00-0.014-0.0830.002
put44.000.000.200.952.3162.000.00-0.045-0.2290.004
put45.000.000.050.052.03671.0010.00-0.039-0.1820.004
put46.000.000.150.182.05245.000.00-0.038-0.1860.004
put47.000.000.750.282.0472.000.00-0.060-0.2620.005
put48.000.000.750.551.9351010.00-0.063-0.2580.006
put49.000.000.751.941.8301.000.00-0.066-0.2550.006
put50.000.000.450.231.68323730.00-0.071-0.2480.006
put51.000.000.550.281.48812330.00-0.079-0.2370.007
put52.000.000.250.481.38912.001.00-0.084-0.2330.007
put53.000.050.300.551.30738.003.00-0.103-0.2540.008
put54.000.100.400.351.26422.006.00-0.134-0.2950.010
put55.000.150.550.441.2398,051317-0.169-0.3270.011
put56.000.400.800.601.25412.0015.00-0.225-0.3920.013
put57.000.451.251.201.3224.002.00-0.295-0.4730.015
put58.000.751.651.051.36930.002.00-0.359-0.5000.017
put59.001.303.002.601.8846051.00-0.433-0.5980.018
put60.001.803.003.431.5952,4212.00-0.504-0.5020.018
put61.001.704.803.852.2868.001.00-0.555-0.6220.018
put62.002.905.606.272.39841.000.00-0.607-0.6290.017
put63.003.806.407.332.4935.000.00-0.693-0.4850.016
put64.004.607.309.782.6301370.00-0.745-0.4490.014
put65.005.908.106.852.69621410.00-0.792-0.4020.013
put66.006.509.3010.002.9111000.00-0.827-0.3780.011
put67.007.4010.208.813.09562.001.00-0.836-0.3920.011
put68.008.4011.2012.003.2544703.00-0.845-0.4080.011
put69.009.3012.2013.403.4072.000.00-0.854-0.4230.010
put70.0010.4013.2014.803.5557860.00-0.861-0.4360.010
put71.0011.3014.1016.333.6343.000.00-0.899-0.3230.008
put72.0012.3015.1014.503.67925.000.00-0.904-0.3320.008
put73.0013.3016.1011.503.90514.000.00-0.907-0.3380.007
put74.0014.3017.1010.004.0341.000.00-0.929-0.2680.006
put75.0015.1018.100.004.1600.000.00-0.931-0.2720.006
put76.0016.1019.100.003.9100.000.00-0.926-0.3200.006
put77.0017.1020.100.004.4010.000.00-0.936-0.2810.006
put78.0018.3021.1020.804.5171.000.00-0.938-0.2850.006
put79.0018.9022.100.004.6300.000.00-0.939-0.2890.005
put80.0019.6023.100.004.3580.000.00-0.942-0.2940.005
put81.0020.9024.100.004.4490.000.00-0.936-0.3420.006
put82.0021.9025.1024.004.6401.000.00-0.945-0.3000.005
put83.0022.7026.100.005.0580.000.00-0.945-0.3020.005
put84.0023.9027.100.004.7440.000.00-0.940-0.3530.005
put85.0025.1028.1023.305.25824.000.00-0.948-0.3080.005
put86.0025.8029.100.004.9450.000.00-0.949-0.3120.005
put87.0026.6030.000.004.9410.000.00-0.943-0.3620.005
put88.0027.5031.100.005.5440.000.00-0.951-0.3160.005
put89.0028.9032.100.005.6360.000.00-0.951-0.3190.005
put90.0029.8033.2035.105.7992.000.00-0.952-0.3210.004
put91.0030.9034.0034.605.2861.000.00-0.947-0.3740.005
put92.0031.7035.1033.495.3680.001.00-0.948-0.3760.005
put93.0032.5036.100.005.6350.000.00-0.955-0.3280.004
put94.0034.1037.000.005.9950.000.00-0.955-0.3300.004
put95.0035.0038.000.005.6220.000.00-0.956-0.3320.004
put10039.5043.200.006.6220.000.00-0.959-0.3420.004
put10544.8048.000.006.8300.000.00-0.961-0.3500.004
put11049.6053.100.007.2490.000.00-0.963-0.3580.004

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-098-KCurrent report2026-11-09SEC
2026-11-06SCHEDULE 13GSEC
2026-09-184Statement of changes in beneficial ownership of securities2026-09-17SEC
2026-09-184Statement of changes in beneficial ownership of securities2026-09-16SEC
2026-09-184Statement of changes in beneficial ownership of securities2026-09-16SEC
2026-09-114Statement of changes in beneficial ownership of securities2026-09-09SEC
2026-09-114Statement of changes in beneficial ownership of securities2026-09-09SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-01144Filing for proposed sale of securities under Rule 144.SEC
2026-09-01144Filing for proposed sale of securities under Rule 144.SEC
2026-08-11SCHEDULE 13GSEC
2026-08-07SCHEDULE 13G/ASEC
2026-08-0310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-038-KCurrent report2026-08-03SEC
2026-07-28SCHEDULE 13GSEC
2026-07-2125-NSESEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-29SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-238-KCurrent report2026-06-18SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-184Statement of changes in beneficial ownership of securities2026-06-16SEC
2026-06-184Statement of changes in beneficial ownership of securities2026-06-16SEC
2026-06-163Initial statement of beneficial ownership of securities2026-06-15SEC
2026-06-168-KCurrent report2026-06-15SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-09001.84M5
2026-080000
2026-070000
2026-0611.11M21.15M5
2026-0582.03M900
2026-0400167.15K2
2026-0313.46M27.77M6
2026-0200850.56K2
2026-0100185.17K2
2025-12002.96M5
2025-11006.09M1

Institutional holders

Manager% owned
Corvex Management LP16.12%
Casdin Capital, LLC12.49%
BlackRock, Inc.5.75%
GOLDMAN SACHS GROUP INC5.62%
ARK Investment Management LLC5.42%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC5.23%
MORGAN STANLEY3.33%
VANGUARD CAPITAL MANAGEMENT LLC2.96%
CITADEL ADVISORS LLC2.92%
First Light Asset Management, LLC2.64%

Funds

Fund% owned
ARK Innovation ETF2.95%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.05%
iShares Russell 2000 ETF1.76%
ARK Genomic Revolution ETF1.51%
Eventide Gilead Fund0.90%
VANGUARD EXTENDED MARKET INDEX FUND0.84%
Harbor Small Cap Growth Fund0.77%
Fidelity Small Cap Index Fund0.74%
T. Rowe Price Health Sciences Fund, Inc.0.70%
Franklin Small Cap Growth Fund0.68%

OakChart. WGS. Cached 15 minutes.